Chào mừng trở lại
Tham gia Cointime
Đăng nhập với email
Đăng nhập với
Đăng ký
Hebei Senlang Biotechnology
About
Hebei Senlang Biotechnology is focused on the treatment of immune cells new technology development and application of high-tech enterprises.
Highlights
Details
- Last Funding Type
- Series B
- Industries
- Biotechnology,Health Care,Pharmaceutical
- Founded date
- Jan 1, 2016
- Operating Status
- Active
Hebei Senlang Biotechnology is focused on the treatment of immune cells new technology development and application of high-tech enterprises.The company has the CAR-T research base (Senrang CAR-T Research Center) in North China, and has formed a high-barrier technology platform such as innovative CAR structural design, virus and cell culture , which can take into account technical research and development, hospital clinical application Provide high-quality and effective cellular immunotherapy support for hematological tumors, solid tumors and other tumor diseases, immune system diseases and other patients.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 1, 2018 | Series B | — | 2 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series B |
Guochuang Investment
|
— | Series B |
